Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Contraception and Contraceptive Drugs

Free Subscription Articles published in Gynecol Endocrinol Retrieve available abstracts of 43 articles: HTML format Text format

Single Articles

January 2019
1. EKENROS L, Backstrom T, Hirschberg AL, Friden C, et al
   Changes in premenstrual symptoms in women starting or discontinuing use of oral contraceptives.
   Gynecol Endocrinol. 2019 Jan 22:1-5. doi: 10.1080/09513590.2018.1534097.
   PubMed     Text format     Abstract available
   
   
   
2. LETE I, Doval JL, Perez-Campos E, Alonso MJ, et al
   Prevention of unintended pregnancies by using emergency contraception: the differences between levonorgestrel and ulipristal acetate. A theoretical model using data from a survey on the use of emergency contraception in Spain, 2017.
   Gynecol Endocrinol. 2019 Jan 7:1-4. doi: 10.1080/09513590.2018.1559286.
   PubMed     Text format     Abstract available
   
   
   
3. PIVA I, Brusca F, Tassinati F, Bonipozzi S, et al
   Post-abortion long-acting reversible contraception in a sample of Italian women: intrauterine device versus subdermal implant.
   Gynecol Endocrinol. 2019 Jan 2:1-7. doi: 10.1080/09513590.2018.1538343.
   PubMed     Text format     Abstract available
   
   
   December 2018
4. SABINE R, Stephanie H, Ariane G, Thomas S, et al
   Successful in vitro maturation for urgent fertility preservation despite hormonal contraception by continuous progestin application.
   Gynecol Endocrinol. 2018 Dec 31:1-3. doi: 10.1080/09513590.2018.1531985.
   PubMed     Text format     Abstract available
   
   
   October 2018
5. WANDRESEN G, Sgarbi F, Nisihara R
   Management of contraceptives and menstrual complaints in patients with Down syndrome.
   Gynecol Endocrinol. 2018 Oct 16:1-6. doi: 10.1080/09513590.2018.1501017.
   PubMed     Text format     Abstract available
   
   
   
6. XU Z, Meng L, Pan C, Chen X, et al
   Does oral contraceptives pretreatment affect the pregnancy outcome in polycystic ovary syndrome women undergoing ART with GnRH agonist protocol?
   Gynecol Endocrinol. 2018 Oct 10:1-4. doi: 10.1080/09513590.2018.1500535.
   PubMed     Text format     Abstract available
   
   
   September 2018
7. MIAO J, Yan Q, Wang L, Wang X, et al
   Three cases of transient hyperthyroidism after triptorelin treatment - case report and literature review.
   Gynecol Endocrinol. 2018;34:734-735.
   PubMed     Text format     Abstract available
   
   
   May 2018
8. STUMPF MAM, Kluthcovsky ACGC, Okamoto JM, Schrut GCA, et al
   Acute pancreatitis secondary to oral contraceptive-induced hypertriglyceridemia: a case report.
   Gynecol Endocrinol. 2018 May 21:1-3. doi: 10.1080/09513590.2018.1473365.
   PubMed     Text format     Abstract available
   
   
   
9. RODRIGUEZ-PURATA J, Devesa M, Parriego M, Pardos C, et al
   Linking back-to-back stimulation cycles with oral contraceptives or progestins in women undergoing embryo accumulation for preimplantation genetic testing, a retrospective study.
   Gynecol Endocrinol. 2018 May 17:1-6. doi: 10.1080/09513590.2018.1473363.
   PubMed     Text format     Abstract available
   
   
   
10. FULGHESU AM, Melis F, Murru G, Canu E, et al
    Very low dose of flutamide in the treatment of hyperandrogenism.
    Gynecol Endocrinol. 2018;34:394-398.
    PubMed     Text format     Abstract available
    
    
    April 2018
11. MANIGLIO P, Ricciardi E, Meli F, Tomao F, et al
    Complete remission of cerebral endometriosis with dienogest: a case report.
    Gynecol Endocrinol. 2018 Apr 20:1-3. doi: 10.1080/09513590.2018.1463362.
    PubMed     Text format     Abstract available
    
    
    
12. ALTINOK ML, Ravn P, Andersen M, Glintborg D, et al
    Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome.
    Gynecol Endocrinol. 2018 Apr 16:1-5. doi: 10.1080/09513590.2018.1460343.
    PubMed     Text format     Abstract available
    
    
    January 2018
13. BRICHANT G, Nervo P, Albert A, Munaut C, et al
    Heterogeneity of estrogen receptor alpha and progesterone receptor distribution in lesions of deep infiltrating endometriosis of untreated women or during exposure to various hormonal treatments.
    Gynecol Endocrinol. 2018 Jan 31:1-5. doi: 10.1080/09513590.2018.1433160.
    PubMed     Text format     Abstract available
    
    
    
14. HERSHKO KLEMENT A, Frederic M, Bentov Y, Chang P, et al
    Oral contraceptive pills as an option for non-surgical management of retained products of conception - a preliminary study.
    Gynecol Endocrinol. 2018 Jan 18:1-3. doi: 10.1080/09513590.2018.1427714.
    PubMed     Text format     Abstract available
    
    
    
15. MORGANTE G, Massaro MG, Di Sabatino A, Cappelli V, et al
    Therapeutic approach for metabolic disorders and infertility in women with PCOS.
    Gynecol Endocrinol. 2018;34:4-9.
    PubMed     Text format     Abstract available
    
    
    December 2017
16. ESTADELLA J, Espanol P, Ascencio F, Perello J, et al
    Ulipristal acetate for the management of acute heavy menstrual bleeding without fibroids.
    Gynecol Endocrinol. 2017 Dec 20:1-4. doi: 10.1080/09513590.2017.1417376.
    PubMed     Text format     Abstract available
    
    
    
17. NERI M, Piras B, Paoletti AM, Vallerino V, et al
    Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women.
    Gynecol Endocrinol. 2017 Dec 19:1-4. doi: 10.1080/09513590.2017.1416465.
    PubMed     Text format     Abstract available
    
    
    November 2017
18. MABROUK M, Paradisi R, Arena A, Del Forno S, et al
    Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial.
    Gynecol Endocrinol. 2017 Nov 21:1-5. doi: 10.1080/09513590.2017.1405932.
    PubMed     Text format     Abstract available
    
    
    October 2017
19. JIN P, Xie Y
    Treatment strategies for women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2017 Oct 31:1-6. doi: 10.1080/09513590.2017.1395841.
    PubMed     Text format     Abstract available
    
    
    September 2017
20. SZUBERT M, Zietara M, Suzin J
    Conservative treatment of deep infiltrating endometriosis: review of existing options.
    Gynecol Endocrinol. 2017 Sep 27:1-5. doi: 10.1080/09513590.2017.1381837.
    PubMed     Text format     Abstract available
    
    
    
21. BALDANI DP, Skrgatic L, Ougouag R, Kasum M, et al
    The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment.
    Gynecol Endocrinol. 2017 Sep 23:1-5. doi: 10.1080/09513590.2017.1381681.
    PubMed     Text format     Abstract available
    
    
    
22. MODAFFARI P, D'alonzo M, Garbagnati M, Pecchio S, et al
    Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review.
    Gynecol Endocrinol. 2017 Sep 21:1-3. doi: 10.1080/09513590.2017.1380186.
    PubMed     Text format     Abstract available
    
    
    June 2017
23. KIM SW, Kim H, Ku SY, Suh CS, et al
    A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer.
    Gynecol Endocrinol. 2017 Jun 26:1-5. doi: 10.1080/09513590.2017.1342239.
    PubMed     Text format     Abstract available
    
    
    
24. SABBIONI L, Petraglia F, Luisi S
    Non-contraceptive benefits of intrauterine levonorgestrel administration: why not?
    Gynecol Endocrinol. 2017 Jun 6:1-8. doi: 10.1080/09513590.2017.1334198.
    PubMed     Text format     Abstract available
    
    
    May 2017
25. NERI M, Malune ME, Corda V, Piras B, et al
    Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC).
    Gynecol Endocrinol. 2017 May 9:1-5. doi: 10.1080/09513590.2017.1322574.
    PubMed     Text format     Abstract available
    
    
    April 2017
26. BAS-LANDO M, Rabinowitz R, Farkash R, Algur N, et al
    Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment.
    Gynecol Endocrinol. 2017 Apr 28:1-4. doi: 10.1080/09513590.2017.1320376.
    PubMed     Text format     Abstract available
    
    
    
27. KEBAPCILAR AG, Ilhan TT, Dursunoglu D, Kebapcilar L, et al
    Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats.
    Gynecol Endocrinol. 2017 Apr 28:1-5. doi: 10.1080/09513590.2017.1320384.
    PubMed     Text format     Abstract available
    
    
    
28. MOROTTI E, Casadio P, Guasina F, Battaglia B, et al
    Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study.
    Gynecol Endocrinol. 2017 Apr 17:1-5. doi: 10.1080/09513590.2017.1306850.
    PubMed     Text format     Abstract available
    
    
    
29. GRANDI G, Mueller MD, Bersinger NA, Facchinetti F, et al
    The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
    Gynecol Endocrinol. 2017 Apr 17:1-4. doi: 10.1080/09513590.2017.1314458.
    PubMed     Text format     Abstract available
    
    
    March 2017
30. SANT'ANNA GD, Brum IS, Branchini G, Pizzolato LS, et al
    Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
    Gynecol Endocrinol. 2017 Mar 16:1-5. doi: 10.1080/09513590.2017.1301924.
    PubMed     Text format     Abstract available
    
    
    
31. TANMAHASAMUT P, Saejong R, Rattanachaiyanont M, Angsuwathana S, et al
    Postoperative desogestrel for pelvic endometriosis-related pain: a randomized controlled trial.
    Gynecol Endocrinol. 2017 Mar 7:1-6. doi: 10.1080/09513590.2017.1296124.
    PubMed     Text format     Abstract available
    
    
    January 2017
32. WILDEMEERSCH D, Goldstuck ND, Jackers G
    Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
    Gynecol Endocrinol. 2017 Jan 13:1-4. doi: 10.1080/09513590.2016.1276164.
    PubMed     Text format     Abstract available
    
    
    
33. MULLER V, Kogan I, Yarmolinskaya M, Niauri D, et al
    Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF.
    Gynecol Endocrinol. 2017;33.
    PubMed     Text format     Abstract available
    
    
    December 2016
34. GUIDA M, Di Carlo C, Troisi J, Gallo A, et al
    The sexuological impact of hormonal contraceptives based on their route of administration.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available
    
    
    November 2016
35. BASTIANELLI C, Farris M, Bruno Vecchio RC, Rosato E, et al
    An observational study of adherence to combined oral contraceptive regimens.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available
    
    
    September 2016
36. SHARIFZADEH F, Aminimoghaddam S, Kashanian M, Fazaeli M, et al
    A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available
    
    
    June 2016
37. SEIKKULA J, Anttila L, Polo-Kantola P, Bloigu R, et al
    Effect of mid-luteal phase GnRH agonist on frozen-thawed embryo transfers during natural menstrual cycles: a randomised clinical pilot study.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available
    
    
    January 2016
38. FENG W, Jia YY, Zhang DY, Shi HR, et al
    Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.
    Gynecol Endocrinol. 2016;32:147-50.
    PubMed     Text format     Abstract available
    
    
    
39. DAKHLY DM, Bayoumi YA, Gad Allah SH
    Which is the best IVF/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial.
    Gynecol Endocrinol. 2016;32:116-9.
    PubMed     Text format     Abstract available
    
    
    
40. PAOLETTI AM, Lello S, Di Carlo C, Orru M, et al
    Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation.
    Gynecol Endocrinol. 2016;32:61-4.
    PubMed     Text format     Abstract available
    
    
    
41. LAGANA AS, Giacobbe V, Triolo O, Granese R, et al
    Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study.
    Gynecol Endocrinol. 2016;32:408-11.
    PubMed     Text format     Abstract available
    
    
    December 2015
42. SAITO F, Tashiro H, Yamaguchi M, Honda R, et al
    Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available
    
    
    July 2015
43. POLYZOS NP, Corona R, Van De Vijver A, Blockeel C, et al
    Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders.
    Gynecol Endocrinol. 2015.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: